OBJECTIVE: The goal of the present study was to identify levels of leukotrienes released by leukocytes and nasal polyps from aspirin-sensitive patients (ASPs) and non-aspirin-sensitive patients (NASPs) after exposure to various concentrations of aspirin. Eosinophil expressions of apoptosis regulators were also compared.
STUDY DESIGN AND SETTING: Leukotriene release from nasal polyps and leukocytes of ASPs and NASPs was measured after exposure to differing concentrations of aspirin. Eosinophils were analyzed for Fas and Fas ligand receptors using flow cytometry.
RESULTS: NASPs showed increased leukotriene release from nasal polyps on increased aspirin exposure. Polyps from ASPs did not show any change. ASPs showed greater leukotriene release from blood on increasing aspirin exposure compared with NASPs. Flow cytometric analysis showed eosinophils in the peripheral blood of ASPs have decreased Fas expression compared with those of NASPs.
CONCLUSIONS: This study showed differences in leukotriene release and eosinophil apoptosis between ASPs and NASPs.
Get full access to this article
View all access options for this article.
References
1.
SamterMBeersRFJr.Intolerance to aspirin: Clinical studies and consideration of its pathogenesis. Ann Intern Med1968;68:975–83.
2.
LeffAR. Toward the formulation of a theory of asthma. Perspect Biol Med1990;33:292–302.
3.
JankowskiR. Eosinophils in the pathophysiology of nasal polyposis. Acta Otolaryngol1996;116:160–3.
4.
KowalskiML. Rhinosinusitis and nasal polyps in aspirin sensitive and aspirin tolerant patients: Are they different?. Thorax2000;55:584–6.
5.
MatsumotoKSchleimerRPSaitoH et al. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood1995;86:1437–43.
6.
HansellTTDeVriesIJIffT et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods1991;145:105–10.
7.
HendersonWRJr.The role of leukotrienes in inflammation. Ann Intern Med1994;121:684–97.
8.
FerreriNRHowlandWCStevensonDD. Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin. An Rev Respir Dis1988;137:847–54.
9.
PicadoCRamisIRoselloJ et al. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirinsensitive asthmatic patients. Am Rev Respir Dis1992;145:65–9.
10.
SpectorSL. Leukotriene inhibitors and antagonists in asthma. Ann Allergy Asthma Immunol1995;75:463–74.
11.
SeedsEAKilfeatherSOkifiS et al. Role of lipoxygenase metabolites in platelet-activating factor and antigen-induced bronchial hyperresponsiveness and eosinophil infiltration. Eur J Pharmacol1995;293:369–76.
12.
KnappHRMurrayJJ. Leukotrienes as mediators of nasal inflammation. Adv Prostagland Thromboxane Leukot Res1994;22:279–87.
13.
SchmidMGodeUSchaferD et al. Arachidonic acid metabolism in nasal tissue and peripheral blood cells in aspirin tolerant asthmatics. Acta Otolaryngol1999;119:277–80.
14.
JungTTKJuhnSKHwangD et al. Prostaglandins, leukotrienes, and other arachidonic acid metabolites in nasal polyps and nasal mucosa. Laryngoscope1987;97:184–9.
15.
SzczeklikA. Aspirin-induced asthma: An update and novel find-ings. Adv Prostagland Thromboxane Leukot Res1994;22:185–97.
16.
HamilosDLLeungDYMWoodR et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol1995;4:537–44.
17.
LazarusSC. Inflammation, inflammatory mediators, and mediator antagonists in asthma. J Clin Pharmacol1998;38:577–82.
18.
FischerARRosenbergMALillyCM et al. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirinsensitive asthma. J Allergy Clin Immunol1994;94:1046–56.
19.
SmithDMGerrardJWhiteJ. Comparison of arachidonic acid metabolism in nasal polyps and eosinophils. Int Arch Allergy Appl Immunol1987;82:83.
20.
SzczeklikAStevensonD. Aspirin-induced asthma: Advances in pathogenesis and management. J Allergy Clin Immunol1999;104:5–13.
21.
PizzichiniEPizzichiniMMEfthmiadisA et al. Measuring airway inflammation in asthma: Eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood. J Allergy Clin Immunol1997;99:539–44.
22.
WoolleyKLGibsonPGCartyK et al. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Respir Crit Care Med1996;154:237–43.
